- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Gabapentin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Gabapentin market size is estimated to be worth US$ 1586.6 million in 2021 and is forecast to a readjusted size of USD 1788.1 million by 2028 with a CAGR of 1.7% during review period. Epilepsy accounting for % of the Gabapentin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Capsule segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gabapentin include Pfizer, Assertio Therapeutics, TEVA, Mylan, and Arbor Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gabapentin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Capsule
Tablet
Market segment by Application can be divided into
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
The key market players for global Gabapentin market are listed below:
Pfizer
Assertio Therapeutics
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gabapentin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gabapentin, with price, sales, revenue and global market share of Gabapentin from 2019 to 2022.
Chapter 3, the Gabapentin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gabapentin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gabapentin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gabapentin.
Chapter 13, 14, and 15, to describe Gabapentin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Gabapentin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gabapentin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Capsule
1.2.3 Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Gabapentin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Global Gabapentin Market Size & Forecast
1.4.1 Global Gabapentin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gabapentin Sales in Volume (2017-2028)
1.4.3 Global Gabapentin Price (2017-2028)
1.5 Global Gabapentin Production Capacity Analysis
1.5.1 Global Gabapentin Total Production Capacity (2017-2028)
1.5.2 Global Gabapentin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gabapentin Market Drivers
1.6.2 Gabapentin Market Restraints
1.6.3 Gabapentin Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Gabapentin Product and Services
2.1.4 Pfizer Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Assertio Therapeutics
2.2.1 Assertio Therapeutics Details
2.2.2 Assertio Therapeutics Major Business
2.2.3 Assertio Therapeutics Gabapentin Product and Services
2.2.4 Assertio Therapeutics Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 TEVA
2.3.1 TEVA Details
2.3.2 TEVA Major Business
2.3.3 TEVA Gabapentin Product and Services
2.3.4 TEVA Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Gabapentin Product and Services
2.4.4 Mylan Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Arbor Pharma
2.5.1 Arbor Pharma Details
2.5.2 Arbor Pharma Major Business
2.5.3 Arbor Pharma Gabapentin Product and Services
2.5.4 Arbor Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Gabapentin Product and Services
2.6.4 Novartis Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Apotex
2.7.1 Apotex Details
2.7.2 Apotex Major Business
2.7.3 Apotex Gabapentin Product and Services
2.7.4 Apotex Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sun Pharmaceutical
2.8.1 Sun Pharmaceutical Details
2.8.2 Sun Pharmaceutical Major Business
2.8.3 Sun Pharmaceutical Gabapentin Product and Services
2.8.4 Sun Pharmaceutical Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Aurobindo Pharma
2.9.1 Aurobindo Pharma Details
2.9.2 Aurobindo Pharma Major Business
2.9.3 Aurobindo Pharma Gabapentin Product and Services
2.9.4 Aurobindo Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Intas
2.10.1 Intas Details
2.10.2 Intas Major Business
2.10.3 Intas Gabapentin Product and Services
2.10.4 Intas Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Amneal
2.11.1 Amneal Details
2.11.2 Amneal Major Business
2.11.3 Amneal Gabapentin Product and Services
2.11.4 Amneal Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Marksans Pharma
2.12.1 Marksans Pharma Details
2.12.2 Marksans Pharma Major Business
2.12.3 Marksans Pharma Gabapentin Product and Services
2.12.4 Marksans Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Glenmark
2.13.1 Glenmark Details
2.13.2 Glenmark Major Business
2.13.3 Glenmark Gabapentin Product and Services
2.13.4 Glenmark Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Alkem
2.14.1 Alkem Details
2.14.2 Alkem Major Business
2.14.3 Alkem Gabapentin Product and Services
2.14.4 Alkem Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Jiangsu Enhua
2.15.1 Jiangsu Enhua Details
2.15.2 Jiangsu Enhua Major Business
2.15.3 Jiangsu Enhua Gabapentin Product and Services
2.15.4 Jiangsu Enhua Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Jiangsu Hengrui
2.16.1 Jiangsu Hengrui Details
2.16.2 Jiangsu Hengrui Major Business
2.16.3 Jiangsu Hengrui Gabapentin Product and Services
2.16.4 Jiangsu Hengrui Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Sailike
2.17.1 Sailike Details
2.17.2 Sailike Major Business
2.17.3 Sailike Gabapentin Product and Services
2.17.4 Sailike Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gabapentin Breakdown Data by Manufacturer
3.1 Global Gabapentin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gabapentin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gabapentin
3.4 Market Concentration Rate
3.4.1 Top 3 Gabapentin Manufacturer Market Share in 2021
3.4.2 Top 6 Gabapentin Manufacturer Market Share in 2021
3.5 Global Gabapentin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gabapentin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gabapentin Market Size by Region
4.1.1 Global Gabapentin Sales in Volume by Region (2017-2028)
4.1.2 Global Gabapentin Revenue by Region (2017-2028)
4.2 North America Gabapentin Revenue (2017-2028)
4.3 Europe Gabapentin Revenue (2017-2028)
4.4 Asia-Pacific Gabapentin Revenue (2017-2028)
4.5 South America Gabapentin Revenue (2017-2028)
4.6 Middle East and Africa Gabapentin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gabapentin Sales in Volume by Type (2017-2028)
5.2 Global Gabapentin Revenue by Type (2017-2028)
5.3 Global Gabapentin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gabapentin Sales in Volume by Application (2017-2028)
6.2 Global Gabapentin Revenue by Application (2017-2028)
6.3 Global Gabapentin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gabapentin Sales by Type (2017-2028)
7.2 North America Gabapentin Sales by Application (2017-2028)
7.3 North America Gabapentin Market Size by Country
7.3.1 North America Gabapentin Sales in Volume by Country (2017-2028)
7.3.2 North America Gabapentin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gabapentin Sales by Type (2017-2028)
8.2 Europe Gabapentin Sales by Application (2017-2028)
8.3 Europe Gabapentin Market Size by Country
8.3.1 Europe Gabapentin Sales in Volume by Country (2017-2028)
8.3.2 Europe Gabapentin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gabapentin Sales by Type (2017-2028)
9.2 Asia-Pacific Gabapentin Sales by Application (2017-2028)
9.3 Asia-Pacific Gabapentin Market Size by Region
9.3.1 Asia-Pacific Gabapentin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gabapentin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gabapentin Sales by Type (2017-2028)
10.2 South America Gabapentin Sales by Application (2017-2028)
10.3 South America Gabapentin Market Size by Country
10.3.1 South America Gabapentin Sales in Volume by Country (2017-2028)
10.3.2 South America Gabapentin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gabapentin Sales by Type (2017-2028)
11.2 Middle East & Africa Gabapentin Sales by Application (2017-2028)
11.3 Middle East & Africa Gabapentin Market Size by Country
11.3.1 Middle East & Africa Gabapentin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gabapentin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gabapentin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gabapentin
12.3 Gabapentin Production Process
12.4 Gabapentin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gabapentin Typical Distributors
13.3 Gabapentin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Gabapentin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Gabapentin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Gabapentin Product and Services
Table 6. Pfizer Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Assertio Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Assertio Therapeutics Major Business
Table 9. Assertio Therapeutics Gabapentin Product and Services
Table 10. Assertio Therapeutics Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. TEVA Basic Information, Manufacturing Base and Competitors
Table 12. TEVA Major Business
Table 13. TEVA Gabapentin Product and Services
Table 14. TEVA Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Mylan Basic Information, Manufacturing Base and Competitors
Table 16. Mylan Major Business
Table 17. Mylan Gabapentin Product and Services
Table 18. Mylan Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Arbor Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Arbor Pharma Major Business
Table 21. Arbor Pharma Gabapentin Product and Services
Table 22. Arbor Pharma Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Gabapentin Product and Services
Table 26. Novartis Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Apotex Basic Information, Manufacturing Base and Competitors
Table 28. Apotex Major Business
Table 29. Apotex Gabapentin Product and Services
Table 30. Apotex Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Sun Pharmaceutical Major Business
Table 33. Sun Pharmaceutical Gabapentin Product and Services
Table 34. Sun Pharmaceutical Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Aurobindo Pharma Major Business
Table 37. Aurobindo Pharma Gabapentin Product and Services
Table 38. Aurobindo Pharma Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Intas Basic Information, Manufacturing Base and Competitors
Table 40. Intas Major Business
Table 41. Intas Gabapentin Product and Services
Table 42. Intas Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Amneal Basic Information, Manufacturing Base and Competitors
Table 44. Amneal Major Business
Table 45. Amneal Gabapentin Product and Services
Table 46. Amneal Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Marksans Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Marksans Pharma Major Business
Table 49. Marksans Pharma Gabapentin Product and Services
Table 50. Marksans Pharma Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Glenmark Basic Information, Manufacturing Base and Competitors
Table 52. Glenmark Major Business
Table 53. Glenmark Gabapentin Product and Services
Table 54. Glenmark Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Alkem Basic Information, Manufacturing Base and Competitors
Table 56. Alkem Major Business
Table 57. Alkem Gabapentin Product and Services
Table 58. Alkem Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Jiangsu Enhua Basic Information, Manufacturing Base and Competitors
Table 60. Jiangsu Enhua Major Business
Table 61. Jiangsu Enhua Gabapentin Product and Services
Table 62. Jiangsu Enhua Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Jiangsu Hengrui Basic Information, Manufacturing Base and Competitors
Table 64. Jiangsu Hengrui Major Business
Table 65. Jiangsu Hengrui Gabapentin Product and Services
Table 66. Jiangsu Hengrui Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Sailike Basic Information, Manufacturing Base and Competitors
Table 68. Sailike Major Business
Table 69. Sailike Gabapentin Product and Services
Table 70. Sailike Gabapentin Sales (M Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global Gabapentin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Unit)
Table 72. Global Gabapentin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in Gabapentin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global Gabapentin Production Capacity by Company, (M Unit): 2020 VS 2021
Table 75. Head Office and Gabapentin Production Site of Key Manufacturer
Table 76. Gabapentin New Entrant and Capacity Expansion Plans
Table 77. Gabapentin Mergers & Acquisitions in the Past Five Years
Table 78. Global Gabapentin Sales by Region (2017-2022) & (M Unit)
Table 79. Global Gabapentin Sales by Region (2023-2028) & (M Unit)
Table 80. Global Gabapentin Revenue by Region (2017-2022) & (USD Million)
Table 81. Global Gabapentin Revenue by Region (2023-2028) & (USD Million)
Table 82. Global Gabapentin Sales by Type (2017-2022) & (M Unit)
Table 83. Global Gabapentin Sales by Type (2023-2028) & (M Unit)
Table 84. Global Gabapentin Revenue by Type (2017-2022) & (USD Million)
Table 85. Global Gabapentin Revenue by Type (2023-2028) & (USD Million)
Table 86. Global Gabapentin Price by Type (2017-2022) & (USD/Unit)
Table 87. Global Gabapentin Price by Type (2023-2028) & (USD/Unit)
Table 88. Global Gabapentin Sales by Application (2017-2022) & (M Unit)
Table 89. Global Gabapentin Sales by Application (2023-2028) & (M Unit)
Table 90. Global Gabapentin Revenue by Application (2017-2022) & (USD Million)
Table 91. Global Gabapentin Revenue by Application (2023-2028) & (USD Million)
Table 92. Global Gabapentin Price by Application (2017-2022) & (USD/Unit)
Table 93. Global Gabapentin Price by Application (2023-2028) & (USD/Unit)
Table 94. North America Gabapentin Sales by Country (2017-2022) & (M Unit)
Table 95. North America Gabapentin Sales by Country (2023-2028) & (M Unit)
Table 96. North America Gabapentin Revenue by Country (2017-2022) & (USD Million)
Table 97. North America Gabapentin Revenue by Country (2023-2028) & (USD Million)
Table 98. North America Gabapentin Sales by Type (2017-2022) & (M Unit)
Table 99. North America Gabapentin Sales by Type (2023-2028) & (M Unit)
Table 100. North America Gabapentin Sales by Application (2017-2022) & (M Unit)
Table 101. North America Gabapentin Sales by Application (2023-2028) & (M Unit)
Table 102. Europe Gabapentin Sales by Country (2017-2022) & (M Unit)
Table 103. Europe Gabapentin Sales by Country (2023-2028) & (M Unit)
Table 104. Europe Gabapentin Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe Gabapentin Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe Gabapentin Sales by Type (2017-2022) & (M Unit)
Table 107. Europe Gabapentin Sales by Type (2023-2028) & (M Unit)
Table 108. Europe Gabapentin Sales by Application (2017-2022) & (M Unit)
Table 109. Europe Gabapentin Sales by Application (2023-2028) & (M Unit)
Table 110. Asia-Pacific Gabapentin Sales by Region (2017-2022) & (M Unit)
Table 111. Asia-Pacific Gabapentin Sales by Region (2023-2028) & (M Unit)
Table 112. Asia-Pacific Gabapentin Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Gabapentin Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific Gabapentin Sales by Type (2017-2022) & (M Unit)
Table 115. Asia-Pacific Gabapentin Sales by Type (2023-2028) & (M Unit)
Table 116. Asia-Pacific Gabapentin Sales by Application (2017-2022) & (M Unit)
Table 117. Asia-Pacific Gabapentin Sales by Application (2023-2028) & (M Unit)
Table 118. South America Gabapentin Sales by Country (2017-2022) & (M Unit)
Table 119. South America Gabapentin Sales by Country (2023-2028) & (M Unit)
Table 120. South America Gabapentin Revenue by Country (2017-2022) & (USD Million)
Table 121. South America Gabapentin Revenue by Country (2023-2028) & (USD Million)
Table 122. South America Gabapentin Sales by Type (2017-2022) & (M Unit)
Table 123. South America Gabapentin Sales by Type (2023-2028) & (M Unit)
Table 124. South America Gabapentin Sales by Application (2017-2022) & (M Unit)
Table 125. South America Gabapentin Sales by Application (2023-2028) & (M Unit)
Table 126. Middle East & Africa Gabapentin Sales by Region (2017-2022) & (M Unit)
Table 127. Middle East & Africa Gabapentin Sales by Region (2023-2028) & (M Unit)
Table 128. Middle East & Africa Gabapentin Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Gabapentin Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa Gabapentin Sales by Type (2017-2022) & (M Unit)
Table 131. Middle East & Africa Gabapentin Sales by Type (2023-2028) & (M Unit)
Table 132. Middle East & Africa Gabapentin Sales by Application (2017-2022) & (M Unit)
Table 133. Middle East & Africa Gabapentin Sales by Application (2023-2028) & (M Unit)
Table 134. Gabapentin Raw Material
Table 135. Key Manufacturers of Gabapentin Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Gabapentin Typical Distributors
Table 139. Gabapentin Typical Customers
List of Figures
Figure 1. Gabapentin Picture
Figure 2. Global Gabapentin Revenue Market Share by Type in 2021
Figure 3. Capsule
Figure 4. Tablet
Figure 5. Global Gabapentin Revenue Market Share by Application in 2021
Figure 6. Epilepsy
Figure 7. Neuropathic Pain
Figure 8. Restless Legs Syndrome
Figure 9. Others
Figure 10. Global Gabapentin Revenue, (USD Million) & (M Unit): 2017 & 2021 & 2028
Figure 11. Global Gabapentin Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Gabapentin Sales (2017-2028) & (M Unit)
Figure 13. Global Gabapentin Price (2017-2028) & (USD/Unit)
Figure 14. Global Gabapentin Production Capacity (2017-2028) & (M Unit)
Figure 15. Global Gabapentin Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Gabapentin Market Drivers
Figure 17. Gabapentin Market Restraints
Figure 18. Gabapentin Market Trends
Figure 19. Global Gabapentin Sales Market Share by Manufacturer in 2021
Figure 20. Global Gabapentin Revenue Market Share by Manufacturer in 2021
Figure 21. Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Gabapentin Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Gabapentin Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Gabapentin Sales Market Share by Region (2017-2028)
Figure 25. Global Gabapentin Revenue Market Share by Region (2017-2028)
Figure 26. North America Gabapentin Revenue (2017-2028) & (USD Million)
Figure 27. Europe Gabapentin Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Gabapentin Revenue (2017-2028) & (USD Million)
Figure 29. South America Gabapentin Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Gabapentin Revenue (2017-2028) & (USD Million)
Figure 31. Global Gabapentin Sales Market Share by Type (2017-2028)
Figure 32. Global Gabapentin Revenue Market Share by Type (2017-2028)
Figure 33. Global Gabapentin Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Gabapentin Sales Market Share by Application (2017-2028)
Figure 35. Global Gabapentin Revenue Market Share by Application (2017-2028)
Figure 36. Global Gabapentin Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Gabapentin Sales Market Share by Type (2017-2028)
Figure 38. North America Gabapentin Sales Market Share by Application (2017-2028)
Figure 39. North America Gabapentin Sales Market Share by Country (2017-2028)
Figure 40. North America Gabapentin Revenue Market Share by Country (2017-2028)
Figure 41. United States Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Gabapentin Sales Market Share by Type (2017-2028)
Figure 45. Europe Gabapentin Sales Market Share by Application (2017-2028)
Figure 46. Europe Gabapentin Sales Market Share by Country (2017-2028)
Figure 47. Europe Gabapentin Revenue Market Share by Country (2017-2028)
Figure 48. Germany Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Gabapentin Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Gabapentin Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Gabapentin Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Gabapentin Revenue Market Share by Region (2017-2028)
Figure 57. China Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Gabapentin Sales Market Share by Type (2017-2028)
Figure 64. South America Gabapentin Sales Market Share by Application (2017-2028)
Figure 65. South America Gabapentin Sales Market Share by Country (2017-2028)
Figure 66. South America Gabapentin Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Gabapentin Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Gabapentin Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Gabapentin Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Gabapentin Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Gabapentin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Gabapentin in 2021
Figure 78. Manufacturing Process Analysis of Gabapentin
Figure 79. Gabapentin Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
